EBITDA: Income before interest, taxes, depreciation and amortization.
Syra Health Corp. (SYRA) had EBITDA of $-0.13M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.73M |
|
$-0.13M |
|
$1.14M |
|
$0.59M |
|
$1.87M |
|
$-0.14M |
|
$0.00M |
|
$-0.13M |
|
$-0.13M |
|
$-0.13M |
|
$-0.13M |
|
$-0.13M |
|
$-0.13M |
|
$-0.14M |
|
|
EBITDA |
$-0.13M |
11.85M |
|
11.85M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$2.74M |
|
$0.01M |
|
$0.03M |
|
$2.77M |
|
$0.67M |
|
-- |
|
-- |
|
$0.67M |
|
$2.10M |
|
$2.10M |
|
$2.10M |
|
11.94M |
|
| Cash Flow Statement Financials | |
$-0.45M |
|
$-0.00M |
|
$-0.33M |
|
$2.40M |
|
$1.61M |
|
$-0.78M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.06 |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
34.09% |
|
-7.82% |
|
-7.82% |
|
-- |
|
-7.76% |
|
-7.76% |
|
$-0.45M |
|
-- |
|
-- |
|
-- |
|
0.63 |
|
-- |
|
1.89 |
|
47.67 |
|
-6.41% |
|
-6.41% |
|
-4.85% |
|
-6.41% |
|
$0.18 |
|
$-0.04 |
|
$-0.04 |
|